Showing posts with label could. Show all posts
Showing posts with label could. Show all posts

Thursday, 3 November 2011

Giant flakes make graphene oxide gel: Discovery could boost metamaterials, high-strength fibers

AppId is over the quota
AppId is over the quota
ScienceDaily (Oct. 20, 2011) — Giant flakes of graphene oxide in water aggregate like a stack of pancakes, but infinitely thinner, and in the process gain characteristics that materials scientists may find delicious.

A new paper by scientists at Rice University and the University of Colorado details how slices of graphene, the single-atom form of carbon, in a solution arrange themselves to form a nematic liquid crystal in which particles are free-floating but aligned.

That much was already known. The new twist is that if the flakes -- in this case, graphene oxide -- are big enough and concentrated enough, they retain their alignment as they form a gel. That gel is a handy precursor for manufacturing metamaterials or fibers with unique mechanical and electronic properties.

The team reported its discovery online this week in the Royal Society of Chemistry journal Soft Matter. Rice authors include Matteo Pasquali, a professor of chemical and biomolecular engineering and of chemistry; James Tour, the T.T. and W.F. Chao Chair in Chemistry as well as a professor of mechanical engineering and materials science and of computer science; postdoctoral research associate Dmitry Kosynkin; and graduate students Budhadipta Dan and Natnael Behabtu. Ivan Smalyukh, an assistant professor of physics at the University of Colorado at Boulder, led research for his group, in which Dan served as a visiting scientist.

"Graphene materials and fluid phases are a great research area," Pasquali said. "From the fundamental point of view, fluid phases comprising flakes are relatively unexplored, and certainly so when the flakes have important electronic properties.

"From the application standpoint, graphene and graphene oxide can be important building blocks in such areas as flexible electronics and conductive and high-strength materials, and can serve as templates for ordering plasmonic structures," he said.

By "giant," the researchers referred to irregular flakes of graphene oxide up to 10,000 times as wide as they are high. (That's still impossibly small: on average, roughly 12 microns wide and less than a nanometer high.) Previous studies showed smaller bits of pristine graphene suspended in acid would form a liquid crystal and that graphene oxide would do likewise in other solutions, including water.

This time the team discovered that if the flakes are big enough and concentrated enough, the solution becomes semisolid. When they constrained the gel to a thin pipette and evaporated some of the water, the graphene oxide flakes got closer to each other and stacked up spontaneously, although imperfectly.

"The exciting part for me is the spontaneous ordering of graphene oxide into a liquid crystal, which nobody had observed before," said Behabtu, a member of Pasquali's lab. "It's still a liquid, but it's ordered. That's useful to make fibers, but it could also induce order on other particles like nanorods."

He said it would be a simple matter to heat the concentrated gel and extrude it into something like carbon fiber, with enhanced properties provided by "mix-ins."

Testing the possibilities, the researchers mixed gold microtriangles and glass microrods into the solution, and found both were effectively forced to line up with the pancaking flakes. Their inclusion also helped the team get visual confirmation of the flakes' orientation.

The process offers the possibility of the large-scale ordering and alignment of such plasmonic particles as gold, silver and palladium nanorods, important components in optoelectronic devices and metamaterials, they reported.

Behabtu added that heating the gel "crosslinks the flakes, and that's good for mechanical strength. You can even heat graphene oxide enough to reduce it, stripping out the oxygen and turning it back into graphite."

Co-authors of the paper are Angel Martinez and Julian Evans, graduate students of Smalyukh at the University of Colorado at Boulder.

The Institute for Complex Adaptive Matter, the Colorado Renewable and Sustainable Energy Initiative, the National Science Foundation, the Air Force Research Lab, the Air Force Office of Scientific Research, the Welch Foundation, the U.S. Army Corps of Engineers Environmental Quality and Installation Program and M-I Swaco supported the research.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by Rice University.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Budhadipta Dan, Natnael Behabtu, Angel Martinez, Julian S. Evans, Dmitry V. Kosynkin, James M. Tour, Matteo Pasquali, Ivan I. Smalyukh. Liquid crystals of aqueous, giant graphene oxide flakes. Soft Matter, 2011; DOI: 10.1039/C1SM06418E

Note: If no author is given, the source is cited instead.

Disclaimer: Views expressed in this article do not necessarily reflect those of ScienceDaily or its staff.


View the original article here

Thursday, 27 October 2011

New insights into insulin resistance could lead to better drugs for diabetics

AppId is over the quota
AppId is over the quota
ScienceDaily (Oct. 20, 2011) — Research published in the October Molecular and Cellular Biology moves us closer to developing drugs that could mitigate diabetes.

Diabetes afflicts an estimated 26 million Americans, while 79 million have prediabetes. In other words, one in three Americans confronts this disease. Diabetes raises the risk of heart disease and stroke by as much as fourfold, and it is the leading cause of blindness among adults 20-74. It is also the leading cause of kidney failure.

In earlier research, four years ago another team of researchers showed that they could boost insulin sensitivity in experimental rodents by giving the animals a drug called myriocin. People with diabetes have a condition called insulin resistance, which renders them poorly able to process sugar. That results in high blood sugar, which damages the blood vessels, leading to many of diabetes' ills. In their study, that team, led by Johannes M. Aerts of the University of Amsterdam, observed a decrease in a compound called ceramide, which sits on cell membranes in the circulatory system, which they postulated was responsible for the rise in insulin sensitivity.

In the new study, Xian-Cheng Jiang of Downstate Medical Center, Brooklyn, NY, and his collaborators set out to confirm this earlier work, using a genetic approach.

The new research provides strong evidence that ceramide was not causing insulin sensitivity, but that another membrane-bound compound, sphingomyelin, might be doing so.

Ceramide is the substrate for the last step in a five step cascade that produces sphingomyelin. In that step an enzyme called sphingomyline synthase 2 (SMS2) cleaves ceramide to produce sphingomyelin. The first enzyme in this pathway is called serine palmitoyltransferase (SPT).

To test the hypothesis that ceramide is involved in modulating insulin resistance the researchers used knockout mice for each of these enzymes. They postulated that (partially) knocking out the first enzyme in the cascade would decrease ceramide levels while knocking out the last enzyme in the sphingomyelin pathway would boost ceramide levels, since that enzyme uses ceramide to produce sphingomyelin. Thus, SPT knockout mice would have greater insulin sensitivity, while SMS knockout mice would have reduced insulin sensitivity.

Surprisingly, while ceramide levels changed as predicted, that change did not influence insulin sensitivity, which was higher in both groups.

The research has important implications for drug development for mitigating diabetes. Myriocin proved highly toxic and major efforts to modify the drug to reduce that toxicity have been fruitless. Myriocin's toxicity probably stems from the fact that it inhibits the first step of the sphingomyelin biosynthetic pathway, affecting all the downstream biology, says Jiang. The discovery that knocking out the last step in the biosynthetic pathway improves insulin sensitivity means that drug treatments could target that last enzyme, SMS, leaving the rest of that biosynthetic pathway to function normally.

Recommend this story on Facebook, Twitter,
and Google +1:

Other bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by American Society for Microbiology.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.

Journal Reference:

Z. Li, H. Zhang, J. Liu, C.-P. Liang, Y. Li, Y. Li, G. Teitelman, T. Beyer, H. H. Bui, D. A. Peake, Y. Zhang, P. E. Sanders, M.-S. Kuo, T.-S. Park, G. Cao, X.-C. Jiang. Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity. Molecular and Cellular Biology, 2011; 31 (20): 4205 DOI: 10.1128/MCB.05893-11

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.


View the original article here